Aflac (AFL) Shares Sold by Argent Trust Co

Argent Trust Co trimmed its stake in Aflac (NYSE:AFL) by 11.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,522 shares of the financial services provider’s stock after selling 583 shares during the period. Argent Trust Co’s holdings in Aflac were worth $397,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of AFL. Rockland Trust Co. grew its position in Aflac by 13.0% during the fourth quarter. Rockland Trust Co. now owns 10,548 shares of the financial services provider’s stock valued at $926,000 after acquiring an additional 1,214 shares during the last quarter. Creative Planning grew its position in Aflac by 2.0% during the fourth quarter. Creative Planning now owns 97,049 shares of the financial services provider’s stock valued at $8,519,000 after acquiring an additional 1,906 shares during the last quarter. Standard Life Aberdeen plc grew its position in Aflac by 172.1% during the fourth quarter. Standard Life Aberdeen plc now owns 515,792 shares of the financial services provider’s stock valued at $45,299,000 after acquiring an additional 326,261 shares during the last quarter. Commerce Bank grew its position in Aflac by 0.4% during the fourth quarter. Commerce Bank now owns 317,814 shares of the financial services provider’s stock valued at $27,897,000 after acquiring an additional 1,335 shares during the last quarter. Finally, Fulcrum Capital LLC bought a new position in Aflac during the fourth quarter valued at approximately $2,985,000. Institutional investors own 68.72% of the company’s stock.

How to Become a New Pot Stock Millionaire

In related news, insider June P. Howard sold 2,648 shares of the firm’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $90.33, for a total value of $239,193.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Charles B. Knapp sold 10,000 shares of the firm’s stock in a transaction on Monday, March 26th. The stock was sold at an average price of $43.72, for a total value of $437,200.00. Following the completion of the sale, the director now directly owns 76,582 shares of the company’s stock, valued at approximately $3,348,165.04. The disclosure for this sale can be found here. Insiders sold 37,631 shares of company stock valued at $2,919,118 in the last ninety days. 3.00% of the stock is currently owned by insiders.

AFL has been the topic of a number of recent research reports. ValuEngine upgraded shares of Aflac from a “buy” rating to a “strong-buy” rating in a research report on Sunday, December 31st. Wells Fargo reiterated a “market perform” rating and set a $45.00 price target (up from $42.00) on shares of Aflac in a research report on Tuesday, January 9th. Zacks Investment Research upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Thursday, January 11th. Janney Montgomery Scott reiterated a “buy” rating on shares of Aflac in a research report on Tuesday, January 16th. Finally, Citigroup raised Aflac to a “strong-buy” rating and increased their price objective for the company from $44.00 to $50.00 in a research note on Monday, January 22nd. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, four have assigned a buy rating and two have given a strong buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $44.68.

Shares of NYSE:AFL traded down $0.33 during trading on Friday, reaching $43.37. 3,570,789 shares of the company traded hands, compared to its average volume of 4,526,548. Aflac has a 52-week low of $36.32 and a 52-week high of $45.88. The firm has a market cap of $34,058.30, a PE ratio of 12.76, a price-to-earnings-growth ratio of 1.72 and a beta of 0.95. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.05 and a current ratio of 0.05.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.02. Aflac had a return on equity of 12.29% and a net margin of 20.18%. The company had revenue of $5.42 billion during the quarter, compared to analyst estimates of $5.44 billion. During the same quarter last year, the firm posted $0.72 earnings per share. The firm’s revenue was down 8.9% on a year-over-year basis. research analysts predict that Aflac will post 3.89 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/07/argent-trust-co-has-397000-holdings-in-aflac-incorporated-afl.html.

Aflac Profile

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply